Beacon Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Beacon Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$280K	Sell	3,992 -24,584	-86%	-$1.65M	0.04%	156
2016 Q4	$1.69M	Sell	28,576 -639	-2%	-$39.4K	0.28%	95
2016 Q3	$1.94M	Sell	29,215 -2,167	-7%	-$134K	0.32%	89
2016 Q2	$1.7M	Sell	31,382 -503	-2%	-$27.6K	0.29%	92
2016 Q1	$1.65M	Buy	31,885 +193	+0.6%	+$10K	0.29%	88
2015 Q4	$2.23M	Sell	31,692 -2,209	-7%	-$151K	0.39%	80
2015 Q3	$2.11M	Buy	+33,901	New	+$2.67M	0.37%	81

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Beacon Trust's XBI Position: Q1 2017 in Review

Beacon Trust reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 86% in Q1 2017, selling an estimated $1.65M and leaving 3,992 shares worth $280K. The position accounts for 0.04% of the portfolio, ranked #156.

Beacon Trust first reported a position in XBI in Q3 2015 and has held it in 7 quarters since. The position peaked at $2.23M in Q4 2015. 292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

Beacon Trust held 3,992 shares of State Street SPDR S&P Biotech ETF worth $280K as of Q1 2017.
Beacon Trust sold 24,584 State Street SPDR S&P Biotech ETF shares in Q1 2017, an estimated $1.65M.
State Street SPDR S&P Biotech ETF made up 0.04% of Beacon Trust's portfolio in Q1 2017, its #156 holding.
Beacon Trust first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and has held it in 7 quarters since.
Beacon Trust's State Street SPDR S&P Biotech ETF position peaked at $2.23M in Q4 2015.
292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.